Haemonetics Corp (HAE)

EBITDA Growth

-30.67%

TTM · Period ending:

HAE logo

HAE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-30.67%
HAE TTM EBITDA YoY % (-76.61% → -30.67%)
High-resolution chart · PNG

HAE ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Haemonetics Corp EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
73.8949%
37.9986%
-1.5527%
-6.3056%
-4.91%
3.7858%
-16.2393%
-16.3352%
-12.1523%
-20.1977%
22.087%
22.6481%
15.9593%
15.3094%
-7.5563%
-12.766%
-12.2206%
-8.9021%
-10.6322%
-3.5191%
-0.8863%
1.6591%
4.5045%
2.8658%
4.1538%
6.08%
11.5578%
16.5202%
21.9512%
23.7624%
25.4202%
30.5046%
33.25%
37.2283%
-27.5495%
-54.2977%
-68.2035%
-76.6052%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.